Article
Wild-type FUS corrects ALS-like disease induced by cytoplasmic mutant FUS through autoregulation.
Molecular neurodegeneration - 6 Sept 2021
Sanjuan-Ruiz Inmaculada, Govea-Perez Noé, McAlonis-Downes Melissa, Dieterle Stéphane, Megat Salim, Dirrig-Grosch Sylvie, Picchiarelli Gina, Piol Diana, Zhu Qiang, Myers Brian, Lee Chao-Zong, Cleveland Don W, Lagier-Tourenne Clotilde, Da Cruz Sandrine, Dupuis Luc
Abstract excerpt
Mutations in FUS, an RNA-binding protein involved in multiple steps of RNA metabolism, are associated with the most severe forms of amyotrophic lateral sclerosis (ALS). Accumulation of cytoplasmic FUS is likely to be a major culprit in the toxicity of FUS mutations. Thus, preventing cytoplasmic mislocalization of the FUS protein may represent a valuable therapeutic strategy. FUS binds to its own pre-mRNA creating...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
